Patents by Inventor Zhiwen DENG

Zhiwen DENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11195332
    Abstract: An information exchange method based on a virtual space scene is performed at a computing device, the method including: obtaining location information of a current terminal; obtaining, according to the location information of the current terminal, map data of a range in which the current terminal is located; drawing, according to the map data, a map in a constructed three-dimensional space, to obtain a drawing result; simulating, according to the drawing result, a real environment of a geographical location of the current terminal in the three-dimensional space, to obtain a virtual space for information exchange; and collecting an operation triggered by at least two terminals in the virtual space, and controlling information exchange processing of the at least two terminals according to a generated operation instruction.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: December 7, 2021
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Jinhui Guo, Bin Li, Zhiwen Deng
  • Patent number: 11045455
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: June 29, 2021
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong Xie, Zejin You, Zhiwen Deng, Jun Zhu, Ao Wang, Yan Feng, Dong Long, Hong Zeng, Hongmei Song, Qijun Ye, Wei Qi, Donghai Su, Lichun Wang, Jingyi Wang
  • Publication number: 20200175760
    Abstract: An information exchange method based on a virtual space scene is performed at a computing device, the method including: obtaining location information of a current terminal; obtaining, according to the location information of the current terminal, map data of a range in which the current terminal is located; drawing, according to the map data, a map in a constructed three-dimensional space, to obtain a drawing result; simulating, according to the drawing result, a real environment of a geographical location of the current terminal in the three-dimensional space, to obtain a virtual space for information exchange; and collecting an operation triggered by at least two terminals in the virtual space, and controlling information exchange processing of the at least two terminals according to a generated operation instruction.
    Type: Application
    Filed: February 3, 2020
    Publication date: June 4, 2020
    Inventors: Jinhui GUO, Bin LI, Zhiwen DENG
  • Publication number: 20200147062
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: January 16, 2020
    Publication date: May 14, 2020
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZENG, Hongmei SONG, Qijun YE, Wei QI, Donghai SU, Lichun WANG, Jingyi WANG
  • Publication number: 20190060291
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 28, 2019
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: YINONG XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZENG, Hongmei SONG, Qijun YE, Wei QI, Donghai SU, Lichun WANG, Jingyi WANG
  • Patent number: 10159662
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: December 25, 2018
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong Xie, Zejin You, Zhiwen Deng, Jun Zhu, Ao Wang, Yan Feng, Dong Long, Hong Zeng, Hongmei Song, Qijun Ye, Wei Qi, Donghai Su, Lichun Wang, Jingyi Wang
  • Publication number: 20180289680
    Abstract: The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, inflammatory diseases, autoimmune diseases, and cancers.
    Type: Application
    Filed: December 8, 2016
    Publication date: October 11, 2018
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Yinong XIE, Zejin YOU, Zhiwen DENG, Jun ZHU, Ao WANG, Yan FENG, Dong LONG, Hong ZHENG, Hongmei SONG, Qijun YE, Wei Qi, Donghai SU, Lichun WANG, Jingyi WANG